ADC Therapeutics SA
For the period ended Dec 31, 2025. Filed Mar 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ADC Therapeutics SA | ||
| /s/ Ameet Mallik | ||
| Date: March 10, 2026 | By: | Ameet Mallik |
|---|---|---|
| Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report has been signed below by the following persons on behalf of the Registrant in the capacities indicated on March 10, 2026.
| Name | Title |
|---|---|
| /s/ Ameet Mallik | Chief Executive Officer and Director(Principal Executive Officer) |
| Ameet Mallik | |
| /s/ Jose Carmona | Chief Financial Officer(Principal Financial Officer) |
| Jose Carmona | |
| /s/ Lisa Kallebo | Corporate Controller and Chief Accounting Officer(Principal Accounting Officer) |
| Lisa Kallebo | |
| /s/ Ron Squarer | Chairman of the Board of Directors |
| Ron Squarer | |
| /s/ Robert Azelby | Director |
| Robert Azelby | |
| /s/ Jean-Pierre Bizzari | Director |
| Jean-Pierre Bizzari | |
| /s/ Peter Hug | Director |
| Peter Hug | |
| /s/ Viviane Monges | Director |
| Viviane Monges | |
| /s/ Timothy Coughlin | Director |
| Timothy Coughlin | |
| /s/ Tyrell Rivers | Director |
| Tyrell Rivers | |
| /s/ Victor Sandor | Director |
| Victor Sandor | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.